Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ESMO 2016 /
Innovative uses of kinase inhibitors in cancer

7th - 11th Oct 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 10.10.16
Views: 1634
Rating:

Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

Dr Rodón talks to ecancertv at ESMO 2016 about the innovative uses of a new kinase inhibitor for angiogenesis and fibroblast growth factor receptors.

He also discusses how some tumours with genetic alterations could benefit from the use of this new class of drug. 

ecancer's filming at ESMO 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation